OneMedPlace recently interviewed CEO Jeffrey Davis about the Dallas-based company’s pipeline.
MuGard: Potential Blockbuster for Oral Mucositis Prevention Market
Oral mucositis is a nearly inevitable complication for patients undergoing chemotherapy or radiation treatment for head or neck cancer.
